Rare but Serious Risks of Medical Marijuana

Weedcoin Team

Understanding Severe Reactions and How to Avoid Them

While most medical marijuana users experience mild side effects, there are rare but serious risks that can significantly impact health if not addressed. At Weedcoin, we’re dedicated to ensuring you have all the facts through the MediWeed Hub with irie vibes. In this article, we’ll dive into the rare but severe risks of medical marijuana, such as psychosis and cannabinoid hyperemesis syndrome (CHS), and how to avoid them. Whether you’re using a strain like Weedcoin OG or managing a chronic condition, this guide will help you stay safe—let’s explore these serious risks in detail!

Warning poster with text 'Serious Risks: Psychosis and CHS' and marijuana leaves.

Although uncommon, medical marijuana can cause severe reactions in certain individuals, particularly with high-THC use. We’ll examine these rare risks and their implications.


Cannabis-Induced Psychosis


High doses of THC can trigger psychosis in susceptible individuals, a rare but serious risk affecting mental health. Doses above 20 mg THC can cause symptoms like hallucinations, delusions, and paranoia, particularly in those with a family history of schizophrenia or bipolar disorder. For example, a patient using 25 mg THC from a potent strain like Weedcoin OG might experience visual distortions or intense paranoia if they have a genetic predisposition. Cannabis-induced psychosis typically resolves within hours to days after stopping use, but as many as half of those who experience it may go on to develop chronic conditions like schizophrenia or bipolar disorder, especially if use continues. The risk is dose-dependent—higher THC levels (e.g., 20% in modern strains) and frequent use increase the likelihood. A European study from 2020 found that high-potency cannabis products carried a greater risk of hallucinations and delusions compared to lower potency types, emphasizing the need for careful strain selection.


Cannabinoid Hyperemesis Syndrome (CHS)


Cannabinoid hyperemesis syndrome (CHS) is another rare but serious risk associated with long-term, heavy cannabis use. CHS causes repeated and severe bouts of nausea, vomiting, and abdominal pain, often requiring hospitalization. It typically occurs in daily users who have consumed cannabis for 10–12 years, affecting about 2% of heavy users. A patient using 1 gram of cannabis daily for a decade might suddenly experience uncontrollable vomiting, with symptoms recurring if use continues. A hallmark of CHS is that hot showers temporarily relieve symptoms, a diagnostic clue for healthcare providers. The only definitive treatment is cessation—symptoms usually resolve within 1–2 weeks of stopping cannabis, but they return if use resumes. The exact cause isn’t fully understood, but it may involve THC’s overstimulation of CB1 receptors in the gut, leading to a paradoxical nausea response.


Risk of Allergic Reactions


Though extremely rare, some patients may experience allergic reactions to cannabis, particularly with inhalation or topical use. Symptoms can range from mild (e.g., skin rash, itchy eyes) to severe (e.g., anaphylaxis, difficulty breathing). Allergies may be triggered by cannabis pollen, mold on improperly stored products, or terpenes like linalool, which is also found in lavender and can cause contact dermatitis. For instance, a patient applying a topical cannabis product with high linalool content might develop a rash, while someone smoking moldy cannabis could experience respiratory distress. These reactions are uncommon but more likely in patients with pre-existing allergies to plants in the Cannabaceae family, such as hops.


Interactions with Medications


Medical marijuana can interact with certain medications, leading to rare but serious risks, especially for patients with complex health conditions. THC and CBD are metabolized by the liver’s cytochrome P450 enzymes, which also process many drugs, potentially altering their effects. For example, CBD can inhibit the metabolism of blood thinners like warfarin, increasing the risk of bleeding—a patient taking 50 mg CBD daily alongside warfarin might experience excessive bruising. THC can enhance the sedative effects of medications like benzodiazepines or opioids, increasing the risk of respiratory depression. A patient combining 10 mg THC with an opioid for pain management might feel dangerously drowsy, posing a risk of overdose. These interactions are rare but more likely in older adults or those on multiple medications.


Risk of Accidental Overdose in Vulnerable Populations


Accidental overdose, while rare, can be a serious risk, particularly for children or elderly patients. High THC doses (e.g., 50 mg) can cause severe symptoms in children, such as lethargy, ataxia, and respiratory depression, often due to accidental ingestion of edibles—Web ID: 1 reports an increase in pediatric ER visits due to cannabis exposure. For elderly patients, high THC doses can exacerbate cardiovascular risks, potentially triggering arrhythmias or fainting, especially if they have heart disease. A 70-year-old patient using 20 mg THC for insomnia might experience a dangerous drop in blood pressure, leading to a fall. Proper storage and dosing are critical to prevent these incidents, particularly in households with vulnerable individuals.


Practical Tips


  • Use low-THC strains (e.g., 10% THC or less) if you have a family history of mental health disorders to reduce psychosis risk. 
  • Stop cannabis use immediately if you experience severe vomiting—consult a doctor and mention CHS as a possible cause. 
  • Test topicals on a small skin patch before full use to check for allergic reactions, especially if you’re sensitive to terpenes like linalool. 
  • Discuss cannabis use with your doctor if you’re on medications like blood thinners—monitor for signs of interactions, such as bruising. 
  • Store cannabis products securely, out of reach of children, and label edibles clearly to prevent accidental ingestion.


Key Takeaways:


  • High THC doses (e.g., 20 mg) can trigger cannabis-induced psychosis, with a risk of progressing to schizophrenia in susceptible individuals. 
  • CHS causes severe vomiting in heavy, long-term users (10–12 years), with hot showers providing temporary relief. 
  • Allergic reactions to cannabis are rare but can include rashes or anaphylaxis, often due to pollen, mold, or terpenes. 
  • THC and CBD can interact with medications like blood thinners, increasing risks like bleeding or sedation. 
  • Accidental overdose in children or the elderly can lead to severe symptoms, emphasizing the need for secure storage.


Glowing cross-section of a human brain with highlighted hippocampus region in warm golden light
By The Weedcoin Team April 14, 2026
A University of Colorado study of 26,000 adults found cannabis users aged 40 to 77 had larger brain volumes and faster processing speeds. Plus a migraine trial.
Empty New Jersey convenience store shelf where hemp products were displayed with dust outlines
By The Weedcoin Team April 13, 2026
A systematic review of 564 fibromyalgia patients found cannabis cut pain scores from 9.0 to 5.0 in six months. NJ hemp shelves go empty today. Seven days to 420.
Texas hemp shop restocking shelves after a judge blocked the statewide smokable hemp ban
By The Weedcoin Team April 12, 2026
A Texas judge blocked the hemp ban. Virginia's governor has until tomorrow. The Medicare CBD hearing lands on 420. And 50,000 people are headed to Denver for it.
Chalk pastel of a shadowy figure behind a frosted glass door with a cannabis leaf shadow
By The Weedcoin Team April 11, 2026
Roger Stone says someone inside the Trump administration is blocking cannabis rescheduling. Spanberger has two days. Massachusetts sent its bill to the governor.
By The Weedcoin Team April 10, 2026
Trump protects medical cannabis in his budget while blocking DC from legalizing. The FBI bans agents from cannabis but allows hemp unless the packaging has a leaf.
Doctor reviewing heart health ECG monitor data with a stethoscope on the desk in a clinic room
By The Weedcoin Team April 9, 2026
A 35-year CARDIA study found no link between cannabis and hypertension. But other major studies show acute cardiovascular risks. Here is the honest full picture.
Young autistic child laughing and building colorful blocks with their father in a sunlit playroom.
By The Weedcoin Team April 8, 2026
A Nature study tracked 82 autistic children on CBD-rich cannabis for six months. Social communication improved on gold-standard assessments. Here is the research.
Empty opioid pill bottles next to cannabis leaves and a recovery journal on a wooden table
By The Weedcoin Team April 7, 2026
New research: states with legal cannabis see a 9-11 point drop in daily opioid use. Over 70% of opioid withdrawal patients report meaningful relief from cannabis.
Elderly man with Parkinson's disease sitting peacefully with his family in a sunlit garden
By The Weedcoin Team April 6, 2026
A new case study shows THC oil reduced Parkinson's motor symptoms by 54.55% in an 83-year-old patient. Here is what the research on cannabis and Parkinson's shows.
Busy cannabis dispensary interior with customers browsing products under warm modern lighting
By The Weedcoin Team April 5, 2026
Legal cannabis revenue projected at $30.5 billion for 2026. Massachusetts fights ballot rollback. DC proposes cannabis-infused drinks. Cannabis skin conditions.
Digital screens displaying red cryptocurrency charts and blockchain data in a darkened trading room
By The Weedcoin Team April 4, 2026
A $280M exploit rattled the Solana ecosystem this week. Cannabis stocks are bleeding under tariff pressure. And CBD is showing real promise for brain injuries.
Elderly woman receiving CBD products from a pharmacist at a pharmacy counter with Medicare forms
By The Weedcoin Team April 3, 2026
A federal judge denied the injunction against Medicare CBD coverage. Trump tariffs are driving up cannabis costs. New Jersey's hemp ban hits in 10 days.
More Posts